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 Physiology of Sex Development 
 Among all definitions of sexual differentiation, we like 
the one from Wikipedia the best: ‘Sexual differentiation 
 is the process of development of the differences between 
males and females from an undifferentiated zygote (fer-
tilized egg). As male and female individuals develop from 
zygotes into fetuses, into infants, children, adolescents, 
and eventually into adults, sex and gender differences at 
many levels develop: genes, chromosomes, gonads, hor-
mones, anatomy, psyche, and social behaviors’ .  In sex de-
velopment we can distinguish two different processes: 
sex determination  that is the developmental decision that 
directs the undifferentiated embryo into a sexually di-
morphic individual and sex differentiation  that takes 
place once the sex determination decision has been made 
through factors produced by the gonads that determine 
the development of the phenotypic sex. At the beginning 
of gestation (1st   and 2nd   week) embryos of the two sexes 
differ only in their karyotypes. Starting at week 3, spe-
cific genes lead to the differentiation of the gonads which 
in turn produce hormones inducing anatomical and psy-
chological differences and lead to behavioral differences 
that are ultimately influenced by the social environment. 
The main steps of intrauterine sex differentiation are de-
picted in  figure 1 . At gestational weeks 6–7 the parame-
sonephric duct (Müllerian duct) develops next to the me-
sonephric duct. If testes develop and secrete testosterone, 
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 Although factors involved in male sexual differentiation 
have been well studied, the pathways regulating female sex-
ual differentiation remain incompletely defined. To date, no 
genes have been identified to play a similar role in ovarian 
development as was shown for the  SRY  or  SOX9  genes in tes-
ticular development. In mice, Wnt4 regulates the develop-
ment of the female reproductive tract, antagonizes the
production of testosterone, and is important for oocyte de-
velopment. The recent demonstration of heterozygous 
 WNT4 defects in patients with Müllerian agenesis and signs 
of ovarian hyperandrogenism added  WNT4 to the growing 
list of genes such as  SRY, SOX9, WT1, DAX1, and  SF-1 contribut-
ing to human sexual development. In particular,  WNT4 was 
the first human gene to be identified to direct development 
of the bipotential gonad towards ovaries. From a more clini-
cal point of view, it seems that the absence of a uterus (and 
not other Müllerian abnormalities) and the androgen excess 
are the pathognomonic signs of WNT4 defects, suggesting 
that WNT4 deficiency might be a clinical entity distinct from 
the typical Mayer-Rokitansky-Kuster-Hauser syndrome. 
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the mesonephric (Wolffian) duct increases in size and 
differentiates into epididymis, vas deferens, and prostate. 
A glycoprotein secreted from the Sertoli cells, known as 
anti-Müllerian hormone (AMH) or Müllerian inhibiting 
substance (MIS), results in Müllerian duct regression. If 
testes do not develop, the mesonephric duct does not 
grow and eventually degenerates, whereas the parameso-
nephric duct proliferates and the fallopian tube, uterus, 
and upper third of the vagina develop ( fig. 2 ).
 In mammals, including humans, the differentiation of 
the gonads is the turning point of this whole process. The 
classical textbook theory says that in the presence of the 
sex determining region on the Y chromosome  (SRY) , the 
default ovarian pathway of sex determination will be in-
hibited and therefore testes will be formed. In the XX in-
dividual, due to the absence of  SRY , no inhibition of the 
default program will take place and ovaries will develop. 
Ovarian determining factors might help the process of 
differentiation. However, these factors are yet to be deter-
mined. The second model, called the Z-factor theory, was 
proposed to explain the cases where XX individuals de-
velop testes in the absence of  SRY . According to this the-
ory, the XX gonad expresses a factor that has both anti-
testis and pro-ovary function.  SRY in XY individuals acts 
as an inhibitor of the Z-factor to lift the block on the male 
pathway. In this case, the bipotential gonad will differen-
tiate into a testis [McElreavey et al., 1993].
 Although factors involved in male sexual differentia-
tion have been well studied ( fig. 3 ), the pathways regulat-
ing female sexual differentiation remain incompletely 
defined. To date, no genes have been identified to play a 
similar role in ovarian development as it was shown for 
the  SRY  or  SOX9  gene in testicular development. In mice, 
Wnt4, one of a few factors with a demonstrated function 
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 Fig. 1. Embryonic development. GW: Gestational week. Data de-
rived from Bertrand et al. [1993]. 
 Fig. 2. The undifferentiated sexual system at 6–7 weeks of gesta-
tion. Precursor structures (top) and their mature counterparts 
(bottom) have the same color. From Stenchever and Goldfarb 
[1998]. 
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 Fig. 3. Sexual differentiation cascade. Mutations in various genes 
(bold) can lead to a variety of syndromes of dysgenesis involving 
the Müllerian or Wolffian ducts, gonads, kidneys, and adrenal 
glands as a result of a deficiency or excess of the proteins shown. 
BMP15: bone morphogenic factor 15;  DAX1 :  dosage dependent 
adrenal hypoplasia congenita on the X chromosome gene 1;  DHH : 
desert hedgehog;  DMRT1 : doublesex- and Mab3-related tran-
scription factor 1;  Emx2 : empty spiracles homeobox gene 2; Fig  : 
factor in germline alpha; Foxl2: forkhead transcription factor; Fst: 
follicostatin; GDF9: growth differentiation factor 9;  GATA-4 : 
gene encoding a protein that binds to a GATA DNA sequence; 
HOXA: homeobox protein;  Lhx9 :  lim homeobox family member; 
 Lim1 : homeobox gene important for limb development; M33: 
polycomb like protein, essential for male sexual differentiation in 
mice; NOBOX: newborn ovary homeobox transcription factor; 
PAX2 :  paired box homeotic gene;  SF-1 : gene for steroidogenic fac-
tor 1;  SRY : sex-determining region of the Y chromosome;  SOX9 : 
SRY homeobox 9;  Wnt4 : wingless-type MMMTV integration site 
family member 4;  WT1 :  Wilms’ tumor-suppressor gene 1. Modi-
fied from McLaughlin and Donahoe [2004]. 
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 Fig. 4. Wnt signaling cascade. When a WNT signal arrives at the 
cell surface, it stimulates the ‘Frizzled’ receptor and/or LDL-recep-
tor related proteins 5 and 6 and arrow. This inhibits the degrada-
tion complex, blocking the elimination of   -catenin.   -Catenin 
migrates to the nucleus and stimulates expression of genes in con-
cert with TCF. That in turn regulates embryonic induction, cell 
polarity, and cell fate. Apc: adenomatous polyposis of the colon; 
  -Cat:   -catenin; Ck1: casein kinase 1; Dvl: disheveled; Fz: friz-
zled; Gsk3: glycogen synthase kinase 3; Lrp: LDL-receptor related 
protein; TCF: T-cell transcription factor. From He et al. [2004]. 
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in the ovarian-determination pathway, has been found to 
be involved in sexual differentiation by suppressing male 
sexual differentiation, promoting Müllerian ducts differ-
entiation, and maintaining oocyte health (see below).
 WNT4 and Sex Development 
 WNT4 (wingless-type MMTV integration site family, 
member 4) is a member of the WNT family of secreted 
molecules that function in a paracrine manner to affect 
a number of developmental changes. Wnt proteins bind 
to members of the frizzled (Fz) family of cell surface re-
ceptors and possibly to the single-pass transmembrane 
protein LDL-receptor-related proteins 5 and 6 (Lrp5 and 
Lrp6) [He et al., 2004]. The binding of Wnt to Fz leads to 
activation of the phosphoprotein dishevelled (Dsh or 
Dvl). The activation and membrane recruitment of Dsh 
probably recruits Axin and the destruction complex to 
the plasma membrane, where Axin directly binds to the 
cytoplasmic tail of Lrp5/6. Axin is then degraded, which 
decreases   -catenin degradation. The activation of Dsh 
also leads to the inhibition of Gsk3, which further reduc-
es the phosphorylation and degradation of   -catenin 
with consequent   -catenin-dependent activation of T-
cell factor/lymphocyte enhancer factor transcription fac-
tors, and induction of Wnt-responsive genes ( fig. 4 ) 
[Nusse, 2003]. Wnt proteins can also signal via  a   -catenin 
independent non-canonical pathway involving protein 
kinase C (Pkc) and c-Jun NH2-terminal kinase (Jnk) 
[Pandur et al., 2002]. (Readers interested in learning more 
about WNT proteins should visit the informative site 
http://www.stanford.edu/  rnusse/wntwindow.html).
 Wnt4 is produced in ovarian somatic cells (pre-granu-
losa cells). It up-regulates  Dax1  [Jordan et al., 2001], a 
gene known to antagonize the nuclear-receptor steroido-
genic factor 1 and thereby inhibits steroidogenic enzymes. 
Vainio and collaborators [Vainio et al., 1999] observed in 
Wnt4 deficient mice that gonadal development and ste-
roidogenic function were affected exclusively in female 
 Wnt4 knockout mice, whereas both male and female mice 
had similar defects in kidney development and adrenal 
function.  Wnt4 knockout female mice were masculin-
ized, as demonstrated by the absence of Müllerian ducts 
and the presence of Wolffian ducts and expressed the ste-
roidogenic enzymes 3  -hydroxysteroid dehydrogenase 
and 17  -hydroxylase, which are required for the produc-
tion of testosterone and are normally suppressed in the 
developing female ovary. The ovaries of these mice also 
had less oocytes suggesting a role of Wnt4 in the life of 
female germ cells. This function is crucial for the organi-
zation of ovarian structure, since female germ cells have 
a central role in this process and in maintenance of the 
ovary, as demonstrated by the fact that when oocytes are 
either absent [Merchant, 1975] or lost after follicle forma-
tion [McLaren, 1984], ovarian follicles never form or de-
generate subsequently. In contrast, testis development 
proceeds in the absence of germ cells. WNT4 and follico-
statin [Yao et al., 2004] appear to maintain oocyte viabil-
ity once germ cells have reached their final destination in 
the gonad. Downstream of WNT4, two oocyte-specific 
transcription factors, among others, also play alpha criti-
cal role in oocyte survival: factor in the germline alpha 
(FIG, FIGLA) [Liang et al., 1997] and newborn ovary 
homeobox-encoding gene (NOBOX) [Rajkovic et al., 
2004]. Absence of these genes results in oocyte death and 
prevents the subsequent formation of primordial follicles 
because of a failure of the ovigerous cords to become fol-
licles [Soyal et al., 2000]. After FIG has been activated 
in oocytes, another transcription factor, forkhead tran-
scription factor FOXL2, is turned on to regulate the dif-
ferentiation of somatic granulosa cells for folliculogene-
sis.  Fbxw15/Fbxo12J , an F-box containing gene specifi-
cally expressed in mouse ovary, was recently shown to 
possibly contribute to ovarian physiology by preventing 
oocytes from exiting meiotic prophase or by regulating 
signaling events required for oocyte–granulosa cell com-
munication [De La Chesnaye et al., 2008]. Bone morpho-
genic protein 15 (BMP15) and growth differentiation fac-
tor 9 (GDF9) are crucial for ovarian follicle physiology, 
probably by controlling its metabolism [Su et al., 2008]. 
In women,  BMP15 and  NOBOX mutations have been as-
sociated with premature ovarian failure [Di Pasquale et 
al., 2004, 2006; Dixit et al., 2006; Qin et al., 2007], where-
as GDF9 aberrant expression and genomic variants have 
been linked to premature ovarian failure and twin preg-
nancy, respectively [Chand et al., 2006; Palmer et al., 
2006; Kovanci et al., 2007].  FOXL2 mutations have been 
associated to blepharophimosis/ptosis/epicanthus inver-
sus syndrome (BPES) and premature ovarian failure 
[Harris et al., 2002]. Maintenance of follicle ‘identity’ is 
guaranteed by estrogen formation and action, as demon-
strated by the transdifferentiation of normally formed 
ovarian tissue into testicular structures in mice lacking 
the enzyme aromatase (converting androgens to estro-
gens) [Britt and Findlay, 2003] and/or estrogen receptor 
[Couse et al., 1999; Dupont et al., 2000]. None of these 
factors, however, except maybe WNT4, have a similar 
role in ovarian development as SRY or SOX9 in testis dif-
ferentiation.  Figure 5 depicts this cascade.
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 WNT4 Deficiency: Implications for Human Sex 
Development 
 In humans, more copies of  WNT4 , due to duplication 
of chromosome 1p31 ] p35, were found in a patient with 
ambiguous genitalia, severe hypospadias, fibrous gonads 
and remnants of both Müllerian and Wolffian ducts [Jor-
dan et al., 2001], i.e., male-to-female sex reversal. On the 
other end of the spectrum, when both copies of the gene 
are inactive, as in the case of homozygote mutations, a 
severe clinical entity called the SERKAL syndrome re-
sults [Mandel et al., 2008]. The syndrome was described 
in three 46,XX fetuses and is characterized by female-to-
male sex reversal with ambiguous genitalia, gonadal 
morphology ranging from ovotestis to normal testis, re-
nal agenesis, adrenal hypoplasia, and pulmonar and car-
diac abnormalities.
 In the middle of such spectrum one might expect to 
find patients with intermediate defects of sex develop-
ment. Searches for clinically relevant  WNT4  mutations 
sometimes in large cohorts of such patients were unsuc-
cessful [Domenice et al., 2004]. We described a woman 
with absent Müllerian structures (uterine and fallopian 
tubes) who had unilateral renal agenesis ( fig. 6 ) and clin-
ical signs of androgen excess. Her phenotype resembles 
that of patients with the Mayer-Rokitansky-Kuster-Haus-
er (MRKH) syndrome and is also strikingly similar to 
that of  Wnt4  knockout female mice. This constellation of 
findings prompted us to search for mutations in the 
 WNT4  gene in this patient.
 Direct sequencing of PCR-amplified exonic fragments 
revealed a heterozygous mutation leading to a heterozy-
gous E226G/WT missense exchange in the WNT4 pro-
tein. In search for causes of the defective signaling, we 
found that the E226G mutant protein appears to be 
trapped inside the cell [Biason-Lauber et al., 2004], likely 
because of defective post-translational lipid modification 
necessary for WNT proper function [Nusse, 2003]. Since 
any generalizations regarding the role of WNT4 in hu-
mans, however, must await the description and charac-
terization of mutations in additional patients, we searched 
for additional subjects with  WNT4 mutations. The recent 
identification of a second [Biason-Lauber et al., 2007] and 
a third patient [Philibert et al., 2008] with a similar phe-
notype and mutations in  WNT4 (R83C and L12P, respec-
tively) confirmed its role in ovarian and female reproduc-
tive tract development in women. The disease-causing 
WNT4 mutations are depicted in  figure 7 . These addi-
tional patients also helped to refine the phenotype of 
WNT4 deficiency in humans. In fact, it appears that the 
absence of a uterus (and not other Müllerian abnormali-
ties) and the androgen excess are the pathognomonic 
signs of WNT4 defects, suggesting that this might be a 
clinical entity distinct from the classical Mayer-Rokitan-
sky-Kuster-Hauser syndrome. The functional studies 
performed in these cases suggested that the consequenc-
es of the present  WNT4 mutations range from lack of lip-
id modification (and probable misfolding) [Biason-Lau-
Germ cells
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Primordial
follicles
formation
WNT4
Fst
FOXL2
Fbxw15
NOBOX
FIG
BMP15
GDF9
Aromatase
ER
Follicle
‘identity’
Primordial
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and
maintenance
 Fig. 5. Simplified diagram of the ovarian 
germ cell/follicle developmental cascade. 
For abbreviations of factors see legend of 
 figure 3 . ER: estrogen receptor. 
 Fig. 6. Magnetic resonance imaging of the abdominal cavity of 
the first WNT4 deficient patient, showing lack of uterus and
tubes (left panel), the renal agenesis, and the ectopic ovary (right 
panel). 
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ber et al., 2004] to misfolding and formation of intracta-
ble aggregates [Biason-Lauber et al., 2007] to defects in 
receptor binding [Philibert et al., 2008]. The fact that 
these patients are heterozygous and the results of the ex-
pression studies suggest that one normal copy of  WNT4 
is not only inadequate to maintain protein function, but 
is also negatively influenced by the mutant protein (dom-
inant negative effect). Although this is not a classical 
gene–dosage phenomenon, since the gene copies are the 
same (except in the duplication case), it is certainly a dos-
age-sensitive sex determining process, as Jordan and co-
workers already predicted [Jordan et al., 2001]. In fact, 
while too much WNT4 activity (duplication) induces 
feminization of the male, too little WNT4 activity (ho-
mozygous loss-of-function mutation) induces exactly the 
opposite, i.e., masculinization of the female. Since WNT4 
inhibits the male development in the female and males do 
not need WNT4 for their sex development [Vainio et al., 
1999], situations between these two extremes are charac-
terized by different degrees of masculinization of the fe-
male. Although the presence of negative dominance ren-
ders the case arithmetically more complex, the relation-
ship between activity levels and phenotype of WNT4 
abnormalities is rather striking ( fig. 8 ) and corroborates 
the idea that sex differentiation is a matter of dosage. A 
general view of the role of WNT4 in sexual development 
is depicted in  figure 9 .
 Conclusions 
 The idea that the female sexual development happens 
by default  was born in the middle of the last century after 
Jost [1970] carried out his innovative experiments to 
study the bases of differentiation of the reproductive tract 
and was based on the fact that the female reproductive 
tract develops even in the absence of any gonad. The term 
default (passive), attributed to the ovarian developmental 
pathway, therefore established itself even if it was not 
originally so intended.
 However, recent findings have demonstrated that 
ovarian development in its early stages is an active pro-
cess. The role of WNT4 (and follicostatin) in this process 
is to suppress the migration of mesonephric endothelial 
and steroidogenic cells preventing the formation of male-
specific coelomic blood vessels and the production of ste-
roids [Jeays-Ward et al., 2003; Yao et al., 2004]. Further-
more, Wnt4 appears to protect the germ cells in mice 
[Vainio et al., 1999] and probably in humans [Philibert et 
al., 2008].
 Although Wnt4/follicostatin has an anti-testis (anti-
coelomic vessel) and a pro-ovarian action (germ cell pro-
tection), they do not fit to the Z-factor profile because 
they influence a marginal aspect of testicular differentia-
tion. Nevertheless, these anti-testis/pro-ovary properties 
and the fact that WNT4/follicostatin are made by somat-
ic cells (similar to what happens for male-specific factors 
in the testis) render the WNT4/follicostatin duo an in-
triguing candidate for the role of the ovarian determin-
ing factor.
 Also, it is appealing to us and others in the field [Yao, 
2005] to speculate that the development of testicular 
structures in XX individuals who do not have SRY or any 
activation of its down-stream targets, points to the pos-
sibility that maybe the development of testes is the default 
 pathway.
 From a more clinical point of view, we agree with 
Clement-Ziza et al. [2005] that it should not be looked
for  WNT4 mutations in MRKH syndrome. However, 
MRKH-like syndromes associated with hyperandrogen-
ism should be investigated for mutations in this gene and 
may classify for a distinct clinical entity.
N
23
1 R83C/WT
L12P/WT A114V
E226G/WT
45 77 90 220 225
361
C
Signal peptide
Lipid-modification site
WNT1 family signature
 Fig. 7. Known mutations in the  WNT4 
gene causing disease. The heterozygote 
mutations were found in women with no 
uterus and signs of virilization. The homo-
zygote mutation (boxed) is linked to a 
more severe entity, called SERKAL syn-
drome. 
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 Future Perspectives 
 Given the role of WNT4  in the maintenance of the fe-
male phenotype of the ovaries, polymorphisms or milder 
defects of this gene and dysregulation of protein function 
are obvious candidates for functional hyperandrogenic 
states such as polycystic ovary (PCO) disease. The altered 
expression of components of WNT signaling in PCO the-
ca cells (demonstrated by gene expression profiling) 
[Wood et al., 2004] suggests an inhibition of the pathway 
and adds further weight to this idea. Thus, there is a need 
for a better characterization of the WNT4 signaling path-
way in ovarian tissues in order to estimate its potential 
contribution to functional hyperandrogenic states. Mod-
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 Fig. 9. WNT4 and human sex develop-
ment. The development of the genital ridge 
and bipotential gonad is under similar 
control in the two sexes. An ovary devel-
ops in the absence of  SRY  and  SOX9  action, 
possibly because of the anti-testis effects of 
 DAX1  and  WNT4.  Steroidogenesis is de-
layed in the ovary by the action of  WNT4, 
 which is also needed for the development 
of the Müllerian ducts and germ cell sur-
vival. A testis develops as a result of  SRY 
 and  SOX9  action, complemented by  DAX1. 
 The regression of the Müllerian ducts is 
mediated by anti-Müllerian hormone 
(AMH) and its receptor (AMH-Rec), 
whereas the androgenic stabilization of 
the Wolffian ducts and the differentiation 
of the external genitalia are mediated by 
the androgen receptor (AR). The descent 
of the testes is partially mediated by the 
insulin-like 3 ligand (Insl3) and its recep-
tor (Lgr8). Modified from Hughes [2004]. 
 Fig. 8. Hypothetical relationship between 
WNT4 dosage and manifestation of dis-
ease. Normal function (and dosage) is set 
as 1.0. Heterozygote mutations have a 
dominant negative effect (red line) on the 
wild type protein and lower the activity by 
20% instead of the expected 50%.  a [Jordan 
et al., 2001];  b [Biason-Lauber et al., 2004, 
2007; Philibert et al., 2008];  c [Mandel et al., 
2008]. 
ulation of WNT4 signaling may turn out to be beneficial 
in the treatment of polycystic ovary disease or other 
forms of hyperandrogenism in future.
 Animal experiments demonstrated that a major role 
of Wnt4 in adrenal development is to prevent the gonad-
al programming of the adrenal cortex. An additional 
function might also include the maintenance of a func-
tional zona glomerulosa, because aldosterone production 
in  Wnt4 –/– mice is significantly reduced [Heikkila et al., 
2002]. Wnt4 is thought to act by inhibiting the synergy 
between   -catenin and Sf-1 on its targets in vitro [Jordan 
et al., 2003] suggesting a role in noncanonical Wnt signal-
ing in adrenals. Although in adult human adrenal glands 
WNT4 is the only member of the WNT family to be ex-
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
Ze
nt
ra
lb
ib
lio
th
ek
 Z
ür
ich
   
   
   
 
13
0.
60
.4
7.
22
 - 
7/
7/
20
16
 1
0:
05
:3
1 
AM
 WNT4 and Sex Development  Sex Dev 2008;2:210–218 217
pressed [Suwa et al., 2003], there is no evidence of im-
paired aldosterone secretion in WNT4 deficient hetero-
zygous patients (normal aldosterone levels, normal PRA, 
normal electrolytes). The homozygous deficient fetuses 
had smaller adrenals (as in mice), but no biochemical 
studies are available. This might be due to species-spe-
cific differences or to the fact that the identified muta-
tions do affect the canonical pathway, but not the non-
canonical. The role of canonical and non-canonical 
WNT4 signaling in human adrenals, with focus on aldo-
sterone production, needs yet to be explored and could 
have implications for the regulation of salt–water balance 
and hypertension. One could even speculate that certain 
polymorphisms of  WNT4 may predispose to or protect 
against the development of essential hypertension.
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